Showing 1 - 20 results of 3,675 for search '(( three ((map decrease) OR (mean decrease)) ) OR ( ai ((larger decrease) OR (marked decrease)) ))', query time: 0.56s Refine Results
  1. 1
  2. 2

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…<p>Similar to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0309489#pone.0309489.g002" target="_blank">Figs 2</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0309489#pone.0309489.g003" target="_blank">3</a> illustrates a series of maps and plots illustrating the effects of different treatments on plaque size. …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…</b> Relative expression of miR-129-5p in the CTX, HIP, and HB regions of saline and LPS treated group. (n = 3 - 10 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.).…”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  20. 20